21-Gene Recurrence Score Index (ONCOTYPE DX) as a predictive biomarker for neoadjuvant chemotherapy response and outcome in patients with HR+HER2-breast cancer

被引：0
|
作者：
Cudos, Ariadna Gasol
Murillo, Serafin Morales
Der-Abrain, Noemi Tuset
Villellas, Felip Vilardell
Cid, Laura Arbones
Olive, Jordi Mele
Morales, Carles Canosa
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-01-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-01-10
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Prognostic significance of complete cell cycle arrest in patients with HR+HER2-breast cancer receiving neoadjuvant chemotherapy
    Moon, S.
    Yoonwon, K.
    SeungHo, B.
    SeungEun, L.
    Junghyun, K.
    Minji, K.
    SoongJune, B.
    Joon, J.
    SaeByul, L.
    SungGwe, A.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 6 - 7
  • [42] 21-Gene Recurrence Score Testing in HER2-positive Patients
    Altman, Ariella M.
    Marmor, Schelomo
    Tuttle, Todd M.
    Hui, Jane Yuet Ching
    CLINICAL BREAST CANCER, 2019, 19 (02) : 126 - 130
  • [43] Outcome disparities by age and 21-gene recurrence score (RS) in hormone receptor positive (HR) breast cancer (BC).
    Petkov, Valentina I.
    Miller, Dave P.
    Howlader, Nadia
    Gliner, Nathan
    Howe, Will
    Schussler, Nicola C.
    Cronin, Kathleen
    Baehner, Frederick L.
    Penberthy, Lynne
    Shak, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patients
    Zeng, Yufei
    Gao, Weiqi
    Chen, Xiaosong
    Shen, Kunwei
    CANCER BIOMARKERS, 2022, 35 (01) : 111 - 118
  • [45] 21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph Nodes
    Tong, Yiwei
    Wu, Jiayi
    Huang, Ou
    He, Jianrong
    Zhu, Li
    Chen, Weiguo
    Li, Yafen
    Chen, Xiaosong
    Shen, Kunwei
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [46] 21-Gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypes
    Wang, Wei
    Lin, Lin
    Fei, Xiaochun
    Hong, Jin
    Gao, Weiqi
    Zhu, Siji
    Wu, Jiayi
    Huang, Ou
    He, Jianrong
    Li, Yafen
    Zhu, Li
    Chen, Weiguo
    Chen, Xiaosong
    Shen, Kunwei
    ONCOLOGY LETTERS, 2019, 18 (04) : 4346 - 4356
  • [47] Survival outcome of adjuvant chemotherapy and high 21-gene recurrence score in early-stage breast cancer
    Ma, Sung Jun
    Oladeru, Oluwadamilola T.
    Farrugia, Mark
    Mikucki, Maryann
    Iovoli, Austin
    Shekher, Rohil
    Sood, Amit
    Singh, Anurag K.
    BREAST JOURNAL, 2021, 27 (01): : 27 - 34
  • [48] The Correlation of Magee Equations™ and Oncotype DX® Recurrence Score From Core Needle Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in ER+ and HER2- Breast Cancer
    Soran, Atilla
    Tane, Kaori
    Sezgin, EFe
    Bhargava, Rohit
    EUROPEAN JOURNAL OF BREAST HEALTH, 2020, 16 (02) : 117 - 123
  • [49] 21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph Nodes
    Yiwei Tong
    Jiayi Wu
    Ou Huang
    Jianrong He
    Li Zhu
    Weiguo Chen
    Yafen Li
    Xiaosong Chen
    Kunwei Shen
    Scientific Reports, 9
  • [50] Impact of OncoType DX™ Recurrence Score and Tumor Size on Making Chemotherapy Decisions in Breast Cancer Patients
    Goodwin, M. C.
    Hughes, J. H.
    Diego, M.
    Frazier, T. G.
    CANCER RESEARCH, 2009, 69 (24) : 835S - 835S
12345